MAR 23, 2018 7:30 AM PDT

Genetic Mutation Provides Protection from Malaria

WRITTEN BY: Kara Marker

A supposedly rare genetic mutation that provides protection from malaria is actually present in one-third of people of African descent. A new study from the Scripps Research Institute shows how the mutation thwarts the invasion of the malaria parasite in a mouse model of disease.

Histopathology of malaria parasite forming in liver. Credit: CDC

Malaria is a disease spread by the Anopheles mosquitoes, caused by a parasite called Plasmodium that first infects liver cells before invading and killing blood cells. A person infected with malaria experiences fever, chills, and flu-like illness. Experts estimate that there were 216 million cases of malaria worldwide in 2016 and 445,000 deaths.

Sickle cell disease is also caused by a genetic mutation that protects against malaria. This mutation leads to abnormally shaped red blood cells, which makes it harder for the malaria parasite to invade them. In sickle cell disease, hemoglobin, a protein in red blood cells which normally carries oxygen through the body, instead forms stiff rods within the cells, changing their shape. Abnormally shaped cells often burst while circulating through the blood vessels. Then the body can’t make enough red blood cells to make up for those lost, causing anemia. Sickle cell disease can also result in blood clots when abnormally shaped cells collect in blood vessels. Experts estimate that 1 in 13 African American babies are born with the sickle cell trait in the United States, and 1 in 365 African American babies are born sickle cell disease.

A new gene mutation being studied, called PIEZO1, was previously thought to be a rare occurrence, but the new study shows that it may be much more common than scientists believed, especially for populations of people who live or lived closely with Anopheles mosquitoes carrying the malaria parasite.

When functioning normally, PIEZO1 codes for a pressure-sensing protein, a role vital for heart development and function. PIEZO1’s deletion causes high blood pressure. The PIEZO1 mutation tested in the new study dehydrates red blood cells, a process called hereditary xerocytosis. This mutation is not common in non-African populations. This new study marks the first time PIEZO1 has been the focus of a large-scale analysis.

Researchers tested the effects of mutated PIEZO1 in a mouse model of malaria. They found the dehydrated blood cells are more difficult for the malaria parasite to infect and cause cerebral malaria, a severe neurological complication of the disease

"This study is a good example of a host/pathogen arms race playing out in real-time--this time with the host a likely winner," described Kristian Andersen, PhD.

Going forward, Andersen and others plan to do a larger-scale genomic association study to confirm PIEZO1’s role in malaria resistance, as well as look for associations in humans.

The present study was published in the journal Cell.

Sources: Centers for Disease Control and Prevention, MedlinePlus.gov, Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 24, 2020
Immunology
Remember That Coronavirus You Once Met? Your T Cells Do.
SEP 24, 2020
Remember That Coronavirus You Once Met? Your T Cells Do.
The SARS-CoV-2 virus was first identified in December 2019 in Wuhan, Hubei, China and quickly escalated to a pandemic st ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
NOV 16, 2020
Immunology
Measles Is Back and COVID Isn't Helping
NOV 16, 2020
Measles Is Back and COVID Isn't Helping
Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person b ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
JAN 12, 2021
Immunology
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
JAN 12, 2021
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
The first organ transplant—performed over 60 years ago—was a success because the donor and recipient were id ...
Loading Comments...